Based in Alpine, New Jersey, John Klein is an experienced pharmaceutical executive who serves as chairman of Cambridge Therapeutics. In addition to his role at Cambridge Therapeutics, John Klein is the founder, chairman, and chief executive officer of Bilogix, LLC, an enterprise performance management (EPM) services provider in Alpine, NJ.
EPM services can be used to improve business operations in several areas, including profitability. An extension of business intelligence investing, EPM services draw on comprehensive analytics to resolve problem areas in an organization and to optimize a business’s strongest areas of development that enhance overall productivity.
Enhanced decision making through corporate performance management is just one of the many benefits of EPM that can lead to improved financial standing. Performance standards are defined and tracked through EPM applications, such as easily accessible scorecards and KPI indexes. Furthermore, processes such as predictive budgeting and business forecasting can have a positive influence on corporate performance management in regards to profitability.